Citations (44)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Angela M. E. P. Naccarato, Sophia Consuelo Souto, Wagner E. Matheus, Ubirajara Ferreira & Fernandes Denardi. (2020) Quality of life and sexual health in men with prostate cancer undergoing radical prostatectomy. The Aging Male 23:5, pages 346-353.
Read now
Read now
Xiao Zhang, Yan Zhong, Farid Saad, Karim Sultan Haider, Ahmad Haider, Angela G. Clendenin & Xiaohui Xu. (2020) Testosterone therapy may reduce prostate cancer risk due to testosterone deficiency at a young age via stabilizing serum testosterone levels. The Aging Male 23:2, pages 112-118.
Read now
Read now
Abraham Morgentaler & Monica Caliber. (2019) Safety of testosterone therapy in men with prostate cancer. Expert Opinion on Drug Safety 18:11, pages 1065-1076.
Read now
Read now
Louis Gooren. (2016) Diagnosing hypogonadism and treating decisions in different parts of the world: shifts in patterns between 2006 and 2015. The Aging Male 19:1, pages 46-53.
Read now
Read now
Hermann M. Behre, Sophie Christin-Maitre, Antonio Martin Morales & Jacques Tostain. (2012) Transversal European survey on testosterone deficiency diagnosis. The Aging Male 15:2, pages 69-77.
Read now
Read now
Louis J. Gooren & Hermann M. Behre. (2012) Diagnosing and treating testosterone deficiency in different parts of the world: changes between 2006 and 2010. The Aging Male 15:1, pages 22-27.
Read now
Read now
Malcolm Carruthers. (2009) Time for international action on treating testosterone deficiency syndrome. The Aging Male 12:1, pages 21-28.
Read now
Read now
Articles from other publishers (37)
Eberhard Nieschlag & Hermann M. Behre. 2023. Andrologie. Andrologie
591
612
.
Eberhard Nieschlag & Hermann M. Behre. 2023. Andrology. Andrology
565
583
.
Tadeusz Ambroży, Łukasz Rydzik, Zbigniew Obmiński, Wiesław Błach, Natalia Serafin, Blanka Błach, Jarosław Jaszczur-Nowicki & Mariusz Ozimek. (2021) The Effect of High-Intensity Interval Training Periods on Morning Serum Testosterone and Cortisol Levels and Physical Fitness in Men Aged 35–40 Years. Journal of Clinical Medicine 10:10, pages 2143.
Crossref
Crossref
Tao Xie, Xian-Lu Song, Chong Wang, Yu-Zhong Yu, Jing-Quan Wang, Zhe-Sheng Chen & Shan-Chao Zhao. (2021) The role of androgen therapy in prostate cancer: from testosterone replacement therapy to bipolar androgen therapy. Drug Discovery Today 26:5, pages 1293-1301.
Crossref
Crossref
Eberhard Nieschlag & Hermann M. Behre. 2020. Andrologie. Andrologie
1
22
.
Eric M. Lo, Adithya Balasubramanian, Alexander W. Pastuszak & Mohit Khera. (2020) Bipolar Androgen Therapy in Prostate Cancer (Update). The Journal of Sexual Medicine 17:5, pages 831-834.
Crossref
Crossref
Michael B. Cook, Daniel C. Beachler, Lauren E. Parlett, Philip T. Cochetti, William D. Finkle, Stephan Lanes & Robert N. Hoover. (2020) Testosterone Therapy in Relation to Prostate Cancer in a U.S. Commercial Insurance Claims Database. Cancer Epidemiology, Biomarkers & Prevention 29:1, pages 236-245.
Crossref
Crossref
Leonardo O. Mendes, Anthony C. S. Castilho, Cristiane F. Pinho, Bianca F. Gonçalvez, Eduardo M. Razza, Luiz Gustavo A. Chuffa, Janete A. Anselmo-Franci, Wellerson R. Scarano & Francisco E. Martinez. (2018) Modulation of inflammatory and hormonal parameters in response to testosterone therapy: Effects on the ventral prostate of adult rats. Cell Biology International 42:9, pages 1200-1211.
Crossref
Crossref
Raymond C. Rosen, Allen D. Seftel, Dustin D. Ruff & David Muram. (2016) A Pilot Study Using a Web Survey to Identify Characteristics That Influence Hypogonadal Men to Initiate Testosterone Replacement Therapy. American Journal of Men's Health 12:3, pages 567-574.
Crossref
Crossref
Bruno Felix-Patrício, Alexandre F. Miranda, Jorge L. Medeiros Jr., Carla B. M. Gallo, Bianca M. Gregório, Diogo B. de Souza, Waldemar S. Costa & Francisco J. B. Sampaio. (2017) The prostate after castration and hormone replacement in a rat model: structural and ultrastructural analysis. International braz j urol 43:5, pages 957-965.
Crossref
Crossref
Mohit Khera, Gregory A. Broderick, Culley C. CarsonIIIIII, Adrian S. Dobs, Martha M. Faraday, Irwin Goldstein, Lawrence S. Hakim, Wayne J.G. Hellstrom, Ravi Kacker, Tobias S. Köhler, Jesse N. Mills, Martin Miner, Hossein Sadeghi-Nejad, Allen D. Seftel, Ira D. Sharlip, Stephen J. Winters & Arthur L. Burnett. (2016) Adult-Onset Hypogonadism. Mayo Clinic Proceedings 91:7, pages 908-926.
Crossref
Crossref
J. A. Steeves, E. C. Fitzhugh, G. Bradwin, K. A. McGlynn, E. A. Platz & C. E. Joshu. (2016) Cross-sectional association between physical activity and serum testosterone levels in US men: results from NHANES 1999-2004. Andrology 4:3, pages 465-472.
Crossref
Crossref
Joseph Scott Gabrielsen, Bobby B. Najari, Joseph P. Alukal & Michael L. Eisenberg. (2016) Trends in Testosterone Prescription and Public Health Concerns. Urologic Clinics of North America 43:2, pages 261-271.
Crossref
Crossref
Culley C. Carson & Roger Kirby. (2015) Prostate Cancer and Testosterone Replacement Therapy—What is the Risk?. Journal of Urology 194:6, pages 1527-1528.
Crossref
Crossref
Krishna Pillai, Mohammad H. Pourgholami, Terence C. Chua & David L. Morris. (2015) Prognostic Significance of Ki67 Expression in Malignant Peritoneal Mesothelioma. American Journal of Clinical Oncology 38:4, pages 388-394.
Crossref
Crossref
Rena D. Malik, Chihsiung E. Wang, Brittany Lapin, Justin C. Lakeman & Brian T. Helfand. (2015) Characteristics of Men Undergoing Testosterone Replacement Therapy and Adherence to Follow-up Recommendations in Metropolitan Multicenter Health Care System. Urology 85:6, pages 1382-1388.
Crossref
Crossref
Rena D. Malik, Brittany Lapin, Chihsiung E. Wang, Justin C. Lakeman & Brian T. Helfand. (2015) Are We Testing Appropriately for Low Testosterone?: Characterization of Tested Men and Compliance with Current Guidelines. The Journal of Sexual Medicine 12:1, pages 66-75.
Crossref
Crossref
Abdulmaged M. Traish. (2014) Testosterone and weight loss. Current Opinion in Endocrinology, Diabetes & Obesity 21:5, pages 313-322.
Crossref
Crossref
Noriaki Kurita, Shigeo Horie, Shin Yamazaki, Kenichi Otoshi, Koji Otani, Miho Sekiguchi, Yoshihiro Onishi, Misa Takegami, Rei Ono, Shin-ichi Konno, Shin-ichi Kikuchi & Shunichi Fukuhara. (2014) Low Testosterone Levels, Depressive Symptoms, and Falls in Older Men: A Cross-Sectional Study. Journal of the American Medical Directors Association 15:1, pages 30-35.
Crossref
Crossref
Ng Kok Kit. 2013. Men's Health. Men's Health
47
54
.
Mark R. Feneley & Malcolm Carruthers. (2012) Is Testosterone Treatment Good for the Prostate? Study of Safety during Long‐Term Treatment. The Journal of Sexual Medicine 9:8, pages 2138-2149.
Crossref
Crossref
Joel M. Kaufman, Michael G. Miller, Sherahe Fitzpatrick, Cecilia McWhirter & John J. Brennan. (2012) One‐Year Efficacy and Safety Study of a 1.62% Testosterone Gel in Hypogonadal Men: Results of a 182‐Day Open‐Label Extension of a 6‐Month Double‐Blind Study. The Journal of Sexual Medicine 9:4, pages 1149-1161.
Crossref
Crossref
Rosmaliza Ramli, Mohd Fadhli Khamis & Ahmad Nazrun Shuid. (2012)
Bone Micro-CT Assessments in an Orchidectomised Rat Model Supplemented with
Eurycoma longifolia
. Evidence-Based Complementary and Alternative Medicine 2012, pages 1-9.
Crossref
Crossref
Joel M. Kaufman, Michael G. Miller, Jeffrey L. Garwin, Sherahe Fitzpatrick, Cecilia McWhirter & John J. Brennan. (2011) Efficacy and Safety Study of 1.62% Testosterone Gel for the Treatment of Hypogonadal Men. The Journal of Sexual Medicine 8:7, pages 2079-2089.
Crossref
Crossref
S. Larry Goldenberg, Anthony Koupparis & Michael E. Robinson. (2011) Differing levels of testosterone and the prostate: a physiological interplay. Nature Reviews Urology 8:7, pages 365-377.
Crossref
Crossref
Abdulmaged M. Traish, Martin M. Miner, Abraham Morgentaler & Michael Zitzmann. (2011) Testosterone Deficiency. The American Journal of Medicine 124:7, pages 578-587.
Crossref
Crossref
Abraham Morgentaler, Larry I. Lipshultz, Richard Bennett, Michael Sweeney, Desiderio Avila & Mohit Khera. (2011) Testosterone Therapy in Men With Untreated Prostate Cancer. Journal of Urology 185:4, pages 1256-1261.
Crossref
Crossref
P. Dandona & M. T. Rosenberg. (2010) A practical guide to male hypogonadism in the primary care setting. International Journal of Clinical Practice 64:6, pages 682-696.
Crossref
Crossref
Eberhard Nieschlag & Hermann M. Behre. 2010. Andrology. Andrology
437
455
.
Claude C. Schulman, Ferdinando Fusco, Antonio Martin Morales, Jacques Tostain, Pedro Vendeira & Michael Zitzmann. (2009) Testosterone Deficiency: A Common, Unrecognised Syndrome?. European Urology Supplements 8:9, pages 772-777.
Crossref
Crossref
Hendrik Isbarn, Jehonathan H. Pinthus, Leonard S. Marks, Francesco Montorsi, Alvaro Morales, Abraham Morgentaler & Claude Schulman. (2009) Testosterone and Prostate Cancer: Revisiting Old Paradigms. European Urology 56:1, pages 48-56.
Crossref
Crossref
. (2009) Current World Literature. Current Opinion in Endocrinology, Diabetes & Obesity 16:3, pages 260-277.
Crossref
Crossref
Jean-Pierre Raynaud. (2009) Testosterone deficiency syndrome: Treatment and cancer risk. The Journal of Steroid Biochemistry and Molecular Biology 114:1-2, pages 96-105.
Crossref
Crossref
Eberhard Nieschlag & Hermann M. Behre. 2009. Andrologie. Andrologie
445
464
.
Donna Rice, Robert E. Brannigan, R. Keith Campbell, Shari Fine, Leonard Jack, Joseph B. Nelson & Janet Regan-Klich. (2009) Men's Health, Low Testosterone, and Diabetes Individualized. The Diabetes Educator 34:5_suppl, pages 97S-112S.
Crossref
Crossref
J. Tostain & C. Coeuret. (2008) Opinion des urologues français sur le syndrome de déficit en testostérone : enquête du comité d’andrologie de l’Afu. Progrès en Urologie 18:9, pages 601-607.
Crossref
Crossref
Abraham Morgentaler. (2008) Guilt by Association: A Historical Perspective on Huggins, Testosterone Therapy, and Prostate Cancer. The Journal of Sexual Medicine 5:8, pages 1834-1840.
Crossref
Crossref